We are live on ! Find out more
BCM

Blume Capital Management Portfolio holdings

AUM $684M
1-Year Est. Return 41.68%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+41.68%
3 Year Est. Return
+96.87%
5 Year Est. Return
+108.87%
10 Year Est. Return
+366.52%
AUM
$166M
AUM Growth
+$3.17M
Cap. Flow
-$1.3M
Cap. Flow %
-0.78%
Top 10 Hldgs %
44.41%
Holding
217
New
17
Increased
28
Reduced
43
Closed
7

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$3.32M
2
KMI icon
Kinder Morgan
KMI
+$1.51M
3
AGN
Allergan plc
AGN
+$1.03M
4
CMCSA icon
Comcast
CMCSA
+$369K
5
VOD icon
Vodafone
VOD
+$168K

Top Sells

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$2.51M
2
TWX
Time Warner Inc
TWX
+$1.82M
3
BKNG icon
Booking.com
BKNG
+$1.78M
4
QCOM icon
Qualcomm
QCOM
+$1.55M
5
MSFT icon
Microsoft
MSFT
+$155K

Sector Composition

Rank Sector Weight
1 Technology 18.39%
2 Energy 18.15%
3 Financials 14.33%
4 Healthcare 12.43%
5 Communication Services 11.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKNG icon
51
Booking.com
BKNG
$149B
$252K 0.15%
4,300
-29,800
-87% -$1.78M
VZ icon
52
Verizon
VZ
$195B
$235K 0.14%
4,408
+353
+9% +$17.6K
V icon
53
Visa
V
$684B
$211K 0.13%
2,702
-43
-2% -$3.46K
PFE icon
54
Pfizer
PFE
$143B
$207K 0.12%
6,718
-559
-8% -$17.1K
INTC icon
55
Intel
INTC
$455B
$197K 0.12%
5,426
+675
+14% +$24.2K
HRL icon
56
Hormel Foods
HRL
$13.8B
$195K 0.12%
5,600
– –
IBM icon
57
IBM
IBM
$211B
$173K 0.1%
1,093
+162
+17% +$24.7K
VOD icon
58
Vodafone
VOD
$36.3B
$166K 0.1%
6,790
+6,390
+1,598% +$168K
LQD icon
59
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$161K 0.1%
1,375
– –
TRV icon
60
Travelers Companies
TRV
$78.1B
$157K 0.09%
1,280
-37
-3% -$4.22K
DE icon
61
Deere & Co
DE
$160B
$144K 0.09%
1,400
– –
PG icon
62
Procter & Gamble
PG
$336B
$139K 0.08%
1,652
-100
-6% -$8.52K
DSI icon
63
iShares MSCI KLD 400 Social ETF
DSI
$5.3B
$136K 0.08%
3,308
+508
+18% +$20.5K
PEP icon
64
PepsiCo
PEP
$190B
$122K 0.07%
1,168
-202
-15% -$21.2K
BMY icon
65
Bristol-Myers Squibb
BMY
$133B
$117K 0.07%
2,005
-48
-2% -$2.62K
BDX icon
66
Becton Dickinson
BDX
$45.6B
$116K 0.07%
719
– –
CELG
67
DELISTED
Celgene Corp
CELG
$116K 0.07%
1,000
– –
AXP icon
68
American Express
AXP
$227B
$111K 0.07%
1,500
-233
-13% -$16.1K
MRK icon
69
Merck
MRK
$322B
$101K 0.06%
1,792
– –
IP icon
70
International Paper
IP
$21.6B
$98K 0.06%
1,958
-55
-3% -$2.54K
SO icon
71
Southern Company
SO
$109B
$94K 0.06%
1,910
– –
PBI icon
72
Pitney Bowes
PBI
$2.37B
$85K 0.05%
5,600
– –
BAC icon
73
Bank of America
BAC
$435B
$82K 0.05%
3,700
– –
WBA
74
DELISTED
Walgreens Boots Alliance
WBA
$79K 0.05%
950
– –
IWB icon
75
iShares Russell 1000 ETF
IWB
$48.2B
$78K 0.05%
627
– –
1 2
3
4 5

Similar funds

HCP
Hexagon Capital Partners Rogers, Arkansas $683M AUM 34.85% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $685M AUM 15.32% 1-Year Est. Return
HWM
Horizon Wealth Management La Grange, Illinois $682M AUM 25.04% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return
DMC
Drexel Morgan & Co Radnor, Pennsylvania $682M AUM 21.01% 1-Year Est. Return
NS
Night Squared New York $681M AUM 50% 1-Year Est. Return
CIA
Covington Investment Advisors Ligonier, Pennsylvania $680M AUM 28.91% 1-Year Est. Return
CCG
Clearlake Capital Group Santa Monica, California $680M AUM 30.34% 1-Year Est. Return

Blume Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Blume Capital Management held 217 positions worth $166M, up 1.9% from $163M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Blume Capital Management's Q4 2016 filing shows 17 new, 28 increased, 43 reduced and 7 closed positions. Its largest new stake was Teva Pharmaceuticals: 83,115 shares worth $3.01M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $2.51M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Energy and Financials.

  • Blume Capital Management's largest Q4 2016 buy was Teva Pharmaceuticals: 83,115 shares worth $3.01M.
  • Blume Capital Management added most to Kinder Morgan in Q4 2016, an estimated $1.51M increase.
  • Blume Capital Management's biggest Q4 2016 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $2.51M.
  • Blume Capital Management fully exited Gen Digital in Q4 2016, selling an estimated $64K.
  • Blume Capital Management's ten largest holdings make up 44% of its $166M portfolio in Q4 2016.
  • Blume Capital Management opened 17 new positions and closed 7 in Q4 2016.
  • Blume Capital Management's portfolio value rose 1.9% quarter-over-quarter to $166M.

Based on Blume Capital Management's 13F filing for Q4 2016, filed 30 Jan 2017.